The Demodex Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Demodex Blepharitis

20251 citationsJournal Articlegold Open Access

Authors

Eric D. Donnenfeld · Ophthalmic Consultants of Long Island

Kelly K. Nichols · University of Alabama at Birmingham

Brandon D. Ayres · Wills Eye Hospital

Marjan Farid · University of California, Irvine

Preeya K. Gupta · Triangle

Richard L. Lindstrom · University of Minnesota

Stephen C. Pflugfelder

Abstract

Experts achieved consensus on the use of lotilaner ophthalmic solution, 0.25% as the first-line treatment for patients with DB. Panelists also agreed that blepharoexfoliation or IPL therapy could serve supplementally to lotilaner ophthalmic solution, 0.25%, if needed.

Topics & Keywords

Acne and Rosacea Treatments and Effects Skin Protection and Aging Psoriasis: Treatment and Pathogenesis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical ophthalmology

Volume Volume 19, pp. 1893-1904

DOI: 10.2147/opth.s525681

Field-Weighted Citation Impact: 2.28